ITC Asks for Comments on Reduced Folate Nutraceuticals Patent Complaint

The International Trade Commission is asking for comments by about Sept. 25 on a Sept. 10 patent complaint filed on behalf of South Alabama Medical Science Foundation, Merck & Cie, and Pamlab LLC, which alleges violations of Section 337 of the Tariff Act of 1930 in the import into the U.S., the sale for import, and the sale within the U.S. after import of certain reduced folate nutraceutical products and L-Methylfolate raw ingredients used therein (D/N 2912). The complaint names as respondents Gnosis SpA of Italy; Gnosis Bioresearch SA of Switzerland; Gnosis USA Inc. of Pa.; and Macoven Pharmaceuticals LLC of Texas. ITC is asking for comments on any public interest issues that might affect ITC consideration, including whether the issuance of an exclusion order and/or cease and desist order would impact the public interest.